Michael G. Schlossmacher

Statistics

Publications

Citations

13.8K

H-Index

Active since

1990

Affiliations

University of Ottawa(Current)

Brigham and Women's Hospital

Harvard University

Ottawa Hospital

Ottawa Hospital Research Institute

Michael G. Schlossmacher is an author at University of Ottawa specializing in life sciences, neurodegenerative diseases, and neurodegenerative disorders.

ORCID

Publications per year

1990–2024

Publications

Amyloid β-peptide is produced by cultured cells during normal metabolism

Christian Haass, Michael G. Schlossmacher, Albert Y. Hung et al. · Nature · 1992 · 1.9K citations

Life Sciences, Biochemistry, Cell Biology +15

Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease

John P. Anderson, Donald E. Walker, Jason Goldstein et al. · Journal of Biological Chemistry · 2006 · 1.4K citations · Full text

Life Sciences, Neurology, Neuroscience +17

Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease

Hideki Shimura, Michael G. Schlossmacher, Nobutaka Hattori et al. · Science · 2001 · 1.1K citations

Life Sciences, Molecular Biology, Neuroscience +17

Dopamine covalently modifies and functionally inactivates parkin

Matthew J. LaVoie, Beth L. Ostaszewski, Andreas Weihofen et al. · Nature Medicine · 2005 · 717 citations

Life Sciences, Neurobiology, Neuroscience +10

Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease

Omar M. A. El‐Agnaf, Sultan A. Salem, Katerina E. Paleologou et al. · The FASEB Journal · 2006 · 709 citations

Life Sciences, Neurology, Neuroscience +17

1–5 of 61